Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Discover the full record of transactions filed by Girao Tiago, Director Financiero. Director active across 2 companies, notably Immunovant, Inc.. In total, 8 reports have been recorded. Split: 0 buy · 3 sells. Total volume traded: €883k. History available since 1 May 2025. The latest transaction was disclosed on 23 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 de 8 declaraciones
Tiago Girao is the Chief Financial Officer of Immunovant, Inc. He is responsible for financial management and strategy, playing a key role in the company's performance.